KYPHON AND INTERNATIONAL MYELOMA FOUNDATION PARTNER TO RAISE AWARENESS OF MULTIPLE MYELOMA THROUGH NATIONAL EDUCATION PROGRAM
"Myeloma Mobile" To Visit Kyphon's Sunnyvale Headquarters
Kyphon Inc. (Nasdaq: KYPH) today announced its partnership with the International Myeloma Foundation (IMF) to raise awareness about multiple myeloma and the various treatment options available to the more than 750,000 people worldwide afflicted with the disease.
Myeloma is the second most common blood cancer after lymphomas. Myeloma is a cancer of the white blood cells and often results in the destruction of bone tissue, resulting in painful fractures. Frequently, the first symptoms of myeloma are pain in the lower back due to vertebral compression fractures that occur in the absence of injury. Approximately 55-70% of those with multiple myeloma suffer vertebral compression fractures. Today, many new drug therapies allow myeloma patients to maintain their daily lives for years and decades. However, the painful fractures caused by myeloma can significantly decrease the quality of life for myeloma patients. Kyphon develops and markets devices used in balloon kyphoplasty, a minimally invasive procedure for the treatment of spinal compression fractures.